Midazolam during continuous haemofiltration. Clinical aspects and pharmacokinetics in ICU patients with multiorgan failure;Utilisation du midazolam en sédation postopératoire chez des patients en défaillance polyviscérale, traités par hémodiafiltration. Étude clinique et pharmacocinétique

Annales Francaises d'Anesthesie et de Reanimation

Volumn 21, Issue 9, 2002, Pages 692-697

  Bastien, Oliver ^a   Bolon, M ^b   Flamens, C ^a   Lehot, J J ^a   Boulieu, R ^b  

^a Service d'Anesthesie Reanimation   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Haemodialysis; ICU; Midazolam; Pharmacokinetics

Indexed keywords

MIDAZOLAM;

ADULT; AGED; ARTICLE; CHROMATOGRAPHY; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG CONJUGATION; HEMOFILTRATION; HUMAN; INTENSIVE CARE; KIDNEY FAILURE; LIVER FAILURE; MEDICAL ASSESSMENT; MULTIPLE ORGAN FAILURE; PLASMA; SEDATION; ULTRAFILTRATION;

ADJUVANTS, ANESTHESIA; AGED; BIOTRANSFORMATION; CHROMATOGRAPHY, LIQUID; FEMALE; HALF-LIFE; HEMOFILTRATION; HUMANS; KIDNEY FAILURE; LIVER FAILURE; MALE; MIDAZOLAM; MIDDLE AGED; MULTIPLE ORGAN FAILURE;

EID: 0036864007     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(02)00777-3     Document Type: Article

References (18)

1. Somma J, Donner A, Zomorodi K, Sladen R, Ramsay J, Geller E, et al. Population pharmacodynamics of midazolam administered by target controlled infusion in SICU patients after CABG surgery. Anesthesiology 1998;89:1430-43.
2. Olivier P, D'Attelis N, Siriex D, Baron JF. Continuous infusion versus bolus administration of sufentanil and midazolam for mitral valve surgery. J Cardiovasc Anesth 1999;13:3-8.
3. Bauer TM, Ritz R, Haberthur C, Ha HR, Hunkeler W, Sleight AJ, et al. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet 1995;346:145-7.
4. Shelly MP, Mendel L, Park GR. Failure of critically ill patients to metabolise midazolam. Anaesthesia 1987;42:619-26.
5. Reetze-Bonorden P, Bohler J, Keller E. Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations. Clin Pharmacokinet 1993;24:362-79.
6. Lehmann B, Boulieu R. Determination of midazolam and its unconjugated 1-hydroxymetabolite in human plasma by high-performance liquid chromatography. J Chromatogr 1995; 674:138-42.
7. Driessen JJ, Vree TB, Guelen PJ. The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients. Acta Anaesthesiol Belg 1991;42:149-55.
8. Bouton V, Bourget P, Lesne-Hulin A, Amstutz P, Benayed M, Benhamou D, et al. Influence of acute renal failure on FPIA rapid serum assay of midazolam and its main metabolite. Int J Clin Pharmacol Ther 1997;35:531-8.
9. Zomorodi K, Donner A, Somma J, Barr J, Sladen R, Ramsay J, et al. Population pharmacokinetics of midazolam administered by target controlled infusion in SICU patients after CABG surgery. Anesthesiology 1998;89:1418-29.
10. Billard V, Cazalaà JB, Servin F, Viviand X. Anesthésie intraveineuse à objectif de concentration. Ann Fr Anesth Réanim 1997;16:250-73.
11. Barr J, Zomorodi K, Bertaccini EJ, Shafer SL, Geller E. A double-blind, randomised comparison of IV lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology 2001;95:286-98.
12. Crevoisier C, Ziegler WH, Heizmann P, Dubuis R. Relation entre l'effet clinique et la concentration plasmatique du midazolam chez les sujets volontaires. Ann Fr Anesth Réanim 1984;3:162-7.
13. Maitre PO, Funk B, Crevoisier C, Ha HR. Pharmacokinetics of midazolam in patients recovering from cardiac surgery. Eur J Clin Pharmacol 1989;37:161-6.
14. Mandema JW, Tuk B, van Steveninck AL, Breimer DD, Cohen AF, Danhof M. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers. Clin Pharmacol Ther 1992;51:715-28.
15. Barr G, Anderson RE, Samuelsson S, Owall A, Jakobsson JG. Fentanyl and midazolam anaesthesia for coronary bypass surgery: A clinical study of bispectral electroencephalogram analysis, drug concentrations and recall. Br J Anaesth 2000;84:749-52.
16. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest 1998;114:541-8.
17. McCollam JS, O'Neil MG, Norcross ED, Byme TK, Reeves ST. Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: A prospective randomised comparison. Crit Care Med 1999;27:2454-8.
18. Walder B, Elia N, Henzi I, Romand JR, Tramèr MR. A lack of evidence of superiority of propofol versus midazolam for sedation in mechanically ventilated critically ill patients: A qualitative and quantitative systematic review. Anesth Analg 2001;92:975-83.